{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T00:38:52Z","timestamp":1771461532367,"version":"3.50.1"},"reference-count":140,"publisher":"Springer Science and Business Media LLC","issue":"S1","license":[{"start":{"date-parts":[[1996,1,1]],"date-time":"1996-01-01T00:00:00Z","timestamp":820454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[1996,1,1]],"date-time":"1996-01-01T00:00:00Z","timestamp":820454400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Basic Res Cardiol"],"published-print":{"date-parts":[[1996,1]]},"DOI":"10.1007\/bf00810519","type":"journal-article","created":{"date-parts":[[2022,2,15]],"date-time":"2022-02-15T19:32:36Z","timestamp":1644953556000},"page":"13-20","source":"Crossref","is-referenced-by-count":36,"title":["Neuroendocrine changes in chronic cardiac failure"],"prefix":"10.1007","volume":"91","author":[{"given":"D. P.","family":"Nicholls","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G. N.","family":"Onuoha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"McDowell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. S.","family":"Elborn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. S.","family":"Riley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. -M.","family":"Nugent","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I. C.","family":"Steele","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Shaw","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K. D.","family":"Buchanan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF00810519_CR1","first-page":"291","volume-title":"Diseases of the Heart and Circulation","author":"P Wood","year":"1969","unstructured":"Wood P (1969) Diseases of the Heart and Circulation. Eyre and Spottiswoode, London, p 291"},{"key":"BF00810519_CR2","doi-asserted-by":"crossref","first-page":"15A","DOI":"10.1016\/0002-9149(85)90791-X","volume":"55","author":"GS Francis","year":"1985","unstructured":"Francis GS (1985) Neurohumoral mechanisms involved in congestive heart failure. Am J Cardiol 55:15A-21A","journal-title":"Am J Cardiol"},{"key":"BF00810519_CR3","first-page":"123","volume":"4","author":"JS Elborn","year":"1993","unstructured":"Elborn JS, Nicholls DP, Riley M, Stanford CF, Buchanan KD (1993) Neuroendocrine responses to change in posture and exercise in patients with chronic cardiac failure. Eur J Int Med 4:123\u2013130","journal-title":"Eur J Int Med"},{"key":"BF00810519_CR4","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1161\/01.CIR.69.6.1079","volume":"69","author":"JR Wilson","year":"1984","unstructured":"Wilson JR, Martin JL, Schwartz D, Ferraro N (1984) Exercise intolerance in patients with chronic heart failure: role of impaired nutritive flow to skeletal muscle. Circulation 69:1079\u20131087","journal-title":"Circulation"},{"key":"BF00810519_CR5","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1161\/01.CIR.76.5.1009","volume":"76","author":"B Massie","year":"1987","unstructured":"Massie B, Conway M, Yonge R et al. (1987) Skeletal muscle metabolism in patients with congestive heart failure: relation to clinical severity and blood flow. Circulation 76:1009\u20131019","journal-title":"Circulation"},{"key":"BF00810519_CR6","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1016\/0140-6736(92)92563-U","volume":"340","author":"Editorial","year":"1992","unstructured":"Editorial (1992) Skeletal muscle in heart failure. Lancet 340:1383\u20131384","journal-title":"Lancet"},{"key":"BF00810519_CR7","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/0140-6736(92)90405-R","volume":"340","author":"M Packer","year":"1992","unstructured":"Packer M (1992) Pathophysiology of chronic heart failure. Lancet 340: 88\u201392","journal-title":"Lancet"},{"key":"BF00810519_CR8","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1056\/NEJM196209272671305","volume":"267","author":"CA Chidsey","year":"1962","unstructured":"Chidsey CA, Harrison DC, Braunwald E (1962) Augmentation of the plasma nor-epinephrine response to exercise in patients with congestive heart failure. N Engl J Med 267:650\u2013654","journal-title":"N Engl J Med"},{"key":"BF00810519_CR9","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/0002-9149(78)90162-5","volume":"41","author":"JA Thomas","year":"1978","unstructured":"Thomas JA, Marks BH (1978) Plasma norepinephrine in congestive heart failure. Am J Cardiol 41:233\u2013243","journal-title":"Am J Cardiol"},{"key":"BF00810519_CR10","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1056\/NEJM198409273111303","volume":"311","author":"JN Cohn","year":"1984","unstructured":"Cohn JN, Levine TB, Olivari MT et al. (1984) Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N Engl J Med 311:819\u2013823","journal-title":"N Engl J Med"},{"key":"BF00810519_CR11","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1161\/01.CIR.82.5.1730","volume":"82","author":"K Swedberg","year":"1990","unstructured":"Swedberg K, Eneroth P, Kjekshus J, Wilhelmsen L (1990) Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. Circulation 82:1730\u20131736","journal-title":"Circulation"},{"key":"BF00810519_CR12","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1161\/01.CIR.67.5.1070","volume":"67","author":"TB Levine","year":"1983","unstructured":"Levine TB, Francis GS, Goldsmith SR, Cohn JN (1983) The neurohumoral and hemodynamic response to orthostatic tilt in patients with congestive heart failure. Circulation 67: 1070\u20131075","journal-title":"Circulation"},{"key":"BF00810519_CR13","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1016\/S0735-1097(83)80041-2","volume":"1","author":"SR Goldsmith","year":"1983","unstructured":"Goldsmith SR, Francis GS, Levine TB, Cohn JN (1983) Regional blood flow response to orthostasis in patients with congestive heart failure. J Am Coll Cardiol 1:1391\u20131395","journal-title":"J Am Coll Cardiol"},{"issue":"Suppl I","key":"BF00810519_CR14","first-page":"87","volume":"61","author":"D Davis","year":"1987","unstructured":"Davis D, Sinoway LI, Robinson J et al. (1987) Norepinephrine kinetics during orthostatic stress in congestive heart failure. Circ Res 61 (Suppl I): 87\u201390","journal-title":"Circ Res"},{"key":"BF00810519_CR15","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1016\/0002-9149(82)90039-X","volume":"49","author":"GS Francis","year":"1982","unstructured":"Francis GS, Goldsmith SR, Ziesche SM, Cohn JN (1982) Response of plasma norepinephrine and epinephrine to dynamic exercise in patients with congestive heart failure. Am J Cardiol 49:1152\u20131156","journal-title":"Am J Cardiol"},{"key":"BF00810519_CR16","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/S0735-1097(85)80420-4","volume":"5","author":"GS Francis","year":"1985","unstructured":"Francis GS, Goldsmith SR, Ziesche S, Nakajima H, Cohn JN (1985) Relative attenuation of sympathetic drive during exercise in patients with congestive heart failure. J Am Coll Cardiol 5:832\u2013839","journal-title":"J Am Coll Cardiol"},{"key":"BF00810519_CR17","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1042\/cs0790089","volume":"79","author":"M Riley","year":"1990","unstructured":"Riley M, Elborn JS, Bell N, Stanford CF, Nicholls DP (1990) Substrate utilisation during exercise in chronic cardiac failure. Clin Sci 79:89\u201395","journal-title":"Clin Sci"},{"key":"BF00810519_CR18","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/S0140-6736(00)49005-7","volume":"i","author":"EH Starling","year":"1897","unstructured":"Starling EH (1897) Some points in the pathology of heart disease. Lancet i:652\u2013655","journal-title":"Lancet"},{"key":"BF00810519_CR19","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1056\/NEJM197110142851602","volume":"285","author":"DL Eckberg","year":"1971","unstructured":"Eckberg DL, Drabinsky M, Braunwald E (1971) Defective cardiac para-sympathetic control in patients with heart disease. N Engl J Med 285:877\u2013883","journal-title":"N Engl J Med"},{"key":"BF00810519_CR20","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/0735-1097(91)90602-6","volume":"18","author":"PF Binkley","year":"1991","unstructured":"Binkley PF, Nunziata E, Haas GJ, Nelson SD, Cody RJ (1991) Parasympathetic withdrawal is an integral component of autonomic imbalance in congestive heart failure: demonstration in human subjects and verification in a paced canine model of ventricular failure. J Am Coll Cardiol 18:464\u2013472","journal-title":"J Am Coll Cardiol"},{"key":"BF00810519_CR21","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1161\/01.CIR.80.2.314","volume":"80","author":"WS Colucci","year":"1989","unstructured":"Colucci WS, Ribeiro JP, Rocco MB et al. (1989) Impaired chronotropic response to exercise in patients with congestive heart failure. Role of postsynaptic \u03b2-adrenergic desensitization. Circulation 80:314\u2013323","journal-title":"Circulation"},{"key":"BF00810519_CR22","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1172\/JCI115659","volume":"89","author":"MR Bristow","year":"1992","unstructured":"Bristow MR, Minobe N, Rasmussen R et al. (1992) \u03b2-adrenergic neuro-effector abnormalities in the failing human heart are produced by local rather than systemic mechanisms. J Clin Invest 89:803\u2013815","journal-title":"J Clin Invest"},{"key":"BF00810519_CR23","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1172\/JCI106865","volume":"51","author":"CB Higgins","year":"1972","unstructured":"Higgins CB, Vatner SF, Eckberg DL, Braunwald E (1972) Alterations in the baroreceptor reflex in conscious dogs with heart failure. J Clin Invest 51:715\u2013724","journal-title":"J Clin Invest"},{"key":"BF00810519_CR24","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1016\/0002-9149(88)91172-1","volume":"61","author":"JP Saul","year":"1988","unstructured":"Saul JP, Arai Y, Berger RD, Lilly LS, Colucci WS, Cohen RJ (1988) Assessment of autonomic regulation in chronic congestive heart failure by heart rate spectral analysis. Am J Cardiol 61:1292\u20131299","journal-title":"Am J Cardiol"},{"key":"BF00810519_CR25","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1161\/01.RES.65.6.1526","volume":"65","author":"ME Dibner-Dunlap","year":"1989","unstructured":"Dibner-Dunlap ME, Thames MD (1989) Baroreflex control of renal sympathetic nerve activity is preserved in heart failure despite reduced arterial barorecepytor sensitivity. Circ Res 65:1526\u20131535","journal-title":"Circ Res"},{"key":"BF00810519_CR26","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1136\/hrt.72.2.150","volume":"72","author":"M Riley","year":"1994","unstructured":"Riley M, P\u00f3rsz\u00e1sz J, Stanford CF, Nicholls DP (1994) Gas exchange responses to constant work rate exercise in chronic cardiac failure. Br Heart J 72:150\u2013155","journal-title":"Br Heart J"},{"key":"BF00810519_CR27","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1042\/cs0870231","volume":"87","author":"M Riley","year":"1994","unstructured":"Riley M, Stanford CF, Nicholls DP (1994) Ventilatory and heart rate responses after exercise in chronic cardiac failure. Clin Sci 87:231\u2013238","journal-title":"Clin Sci"},{"key":"BF00810519_CR28","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1042\/cs0800633","volume":"80","author":"M Riley","year":"1991","unstructured":"Riley M, Elborn JS, McKane WR, Bell N, Stanford CF, Nicholls DP (1991) Resting energy expenditure in chronic cardiac failure. Clin Sci 80:633\u2013639","journal-title":"Clin Sci"},{"key":"BF00810519_CR29","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1042\/cs0610585","volume":"61","author":"MJ Brown","year":"1981","unstructured":"Brown MJ, Jenner DA, Allison DJ, Dollery Ct (1981) Variations in individual organ release of noradrenaline measured by an improved radioenzymatic technique; limitations of peripheral venous measurements in the assessment of sympathetic nervous activity. Clin Sci 61:585\u2013590","journal-title":"Clin Sci"},{"key":"BF00810519_CR30","first-page":"772","volume":"101","author":"RD Hoeldtke","year":"1983","unstructured":"Hoeldtke RD, Cilmi KM, Reichard GA, Owen OE (1983) Assessment of norepinephrine secretion and production. J Lab Clin Med 101:772\u2013782","journal-title":"J Lab Clin Med"},{"key":"BF00810519_CR31","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/j.1476-5381.1977.tb07526.x","volume":"60","author":"SZ Langer","year":"1977","unstructured":"Langer SZ (1977) Presynaptic receptors and their role in the regulation of transmitter release. Br J Pharmacol 60:481\u2013497","journal-title":"Br J Pharmacol"},{"key":"BF00810519_CR32","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1161\/01.CIR.78.3.516","volume":"78","author":"GJ Hasking","year":"1988","unstructured":"Hasking GJ, Esler MD, Jennings GL, Dewar E, Lambert G (1988) Norepinephrine spillover to plasma during steady-state supine bicycle exercise. Comparison of patients with congestive heart failure and normal subjects. Circulation 78:516\u2013521","journal-title":"Circulation"},{"key":"BF00810519_CR33","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1161\/01.CIR.88.1.136","volume":"88","author":"IT Meredith","year":"1993","unstructured":"Meredith IT, Eisenhofer G, Lambert GW, Dewar EM, Jennings GL, Esler MD (1993) Cardiac sympathetic nervous activity in congestive heart failure. Evidence for increased neuronal norepinephrine release and preserved neuronal uptake. Circulation 88:136\u2013145","journal-title":"Circulation"},{"key":"BF00810519_CR34","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/0002-8703(70)90098-0","volume":"80","author":"JJ Brown","year":"1970","unstructured":"Brown JJ, Davies DL, Johnson VW, Lever AF, Robertson JIS (1970) Renin relationships in congestive cardiac failure, treated and untreated. Am Heart J 80:329\u2013342","journal-title":"Am Heart J"},{"key":"BF00810519_CR35","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1016\/0002-9149(82)90243-0","volume":"49","author":"TB Levine","year":"1982","unstructured":"Levine TB, Francis GS, Goldsmith SR, Simon AB, Cohn JN (1982) Activity of the sympathetic nervous system and renin-angiotensin system assessed by plasma hormone levels and their relationship to hemodynamic abnormalities in congestive heart failure. Am J Cardiol 49:1659\u20131666","journal-title":"Am J Cardiol"},{"key":"BF00810519_CR36","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1161\/01.RES.53.5.630","volume":"53","author":"GD Johnston","year":"1983","unstructured":"Johnston GD, Hiatt WR, Nies AS, Payne NA, Murphy RC, Gerber JG (1983) Factors modifying the early non-diuretic vascular effects of furosemide in man. Circ Res 53:630\u2013635","journal-title":"Circ Res"},{"key":"BF00810519_CR37","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1172\/JCI108431","volume":"57","author":"L Watkins","year":"1976","unstructured":"Watkins L, Burton JA, Haber E, Cant JR, Smith AW, Barger AC (1976) The renin-angiotensin-aldosterone system in congestive failure in conscious dogs. J Clin Invest 57:1606\u20131617","journal-title":"J Clin Invest"},{"key":"BF00810519_CR38","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1136\/hrt.57.1.17","volume":"57","author":"J Bayliss","year":"1987","unstructured":"Bayliss J, Norell M, Canepa-Anson R, Sutton G, Poole-Wilson P (1987) Untreated heart failure: clinical and neuroendocrine effects of introducing diuretics. Br Heart J 57:17\u201322","journal-title":"Br Heart J"},{"key":"BF00810519_CR39","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1093\/oxfordjournals.eurheartj.a059429","volume":"10","author":"M Broqvist","year":"1989","unstructured":"Broqvist M, Dahlstrom U, Karlberg BE, Karlsson E, Markland T (1989) Neuroendocrine response in acute heart failure and the influence of treatment. Eur Heart J 10:1075\u20131083","journal-title":"Eur Heart J"},{"key":"BF00810519_CR40","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1161\/01.CIR.82.5.1724","volume":"82","author":"GS Francis","year":"1990","unstructured":"Francis GS, Benedict C, Johnstone DE et al. (1990) Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure. A substudy of the Studies of Left Ventricular Dysfunction (SOLVD). Circulation 82:1724\u20131729","journal-title":"Circulation"},{"key":"BF00810519_CR41","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/0002-8703(81)90739-0","volume":"102","author":"JN Cohn","year":"1981","unstructured":"Cohn JN, Levine TB, Francis GS, Goldsmith S (1981) Neurohumoral control mechanisms in congestive heart failure. Am Heart J 102:509\u2013514","journal-title":"Am Heart J"},{"key":"BF00810519_CR42","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1161\/01.CIR.63.3.645","volume":"63","author":"VJ Dzau","year":"1981","unstructured":"Dzau VJ, Colucci WS, Hollenberg NK, Williams GH (1981) Relation of the renin-angiotensin-aldosterone system to clinical state in congestive heart failure. Circulation 63:645\u2013651","journal-title":"Circulation"},{"key":"BF00810519_CR43","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1172\/JCI105561","volume":"46","author":"RD Gordon","year":"1967","unstructured":"Gordon RD, K\u00fcchel O, Liddle GW, Island DP (1967) Role of the sympathetic nervous system in regulating renin and aldosterone production in man. J Clin Invest 46:599\u2013605","journal-title":"J Clin Invest"},{"key":"BF00810519_CR44","first-page":"81","volume":"31","author":"TK Keeton","year":"1980","unstructured":"Keeton TK, Campbell WB (1980) The pharmacological alteration of renin release. Pharmacol Rev 31:81\u2013227","journal-title":"Pharmacol Rev"},{"key":"BF00810519_CR45","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1002\/dmr.5610010404","volume":"1","author":"H Galbo","year":"1986","unstructured":"Galbo H (1986) The hormonal response to exercise. Diab Metab Revs 1:385\u2013408","journal-title":"Diab Metab Revs"},{"key":"BF00810519_CR46","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1093\/oxfordjournals.eurheartj.a060073","volume":"13","author":"DP Nicholls","year":"1992","unstructured":"Nicholls DP, Riley M, Elborn JS et al. (1992) Regulatory peptides in the plasma of patients with chronic cardiac failure at rest and during exercise. Eur Heart J 13:1399\u20131404","journal-title":"Eur Heart J"},{"key":"BF00810519_CR47","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1136\/bmj.1.5492.920-c","volume":"i","author":"S Toivonen","year":"1966","unstructured":"Toivonen S, Mustala O (1966) Diabetogenic action of frusemide. Br Med J i:920\u2013921","journal-title":"Br Med J"},{"key":"BF00810519_CR48","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1016\/0026-0495(91)90075-8","volume":"40","author":"G Paolisso","year":"1991","unstructured":"Paolisso G, De Riu S, Marrazzo G, Verza M, Varricchio M, D'Onofrio F (1991) Insulin resistance and hyperin-sulinaemia in patients with chronic congestive heart failure. Metabolism 40:972\u2013977","journal-title":"Metabolism"},{"key":"BF00810519_CR49","first-page":"131","volume":"87","author":"RA Wright","year":"1994","unstructured":"Wright RA, Flapan AD, Stenhouse F et al. (1994) Hyperinsulinaemia in ischaemic heart disease: the importance of myocardial infarction and left ventricular function. Quart J Med 87:131\u2013138","journal-title":"Quart J Med"},{"key":"BF00810519_CR50","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1098\/rspl.1901.0119","volume":"69","author":"WM Bayliss","year":"1902","unstructured":"Bayliss WM, Starling EH (1902) On the causation of the so-called \u2018Peripheral Reflex Secretion\u2019 of the pancreas. Proc Roy Soc Lond 69:352\u2013353","journal-title":"Proc Roy Soc Lond"},{"key":"BF00810519_CR51","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1093\/oxfordjournals.eurheartj.a062037","volume":"7","author":"P Gunnes","year":"1986","unstructured":"Gunnes P, Rasmussen K (1986) Haemodynamic effects of pharmacological doses of secretin in patients with impaired left ventricular function. Eur Heart J 7:146\u2013149","journal-title":"Eur Heart J"},{"key":"BF00810519_CR52","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/0033-0620(82)90012-3","volume":"24","author":"R Zelis","year":"1982","unstructured":"Zelis R, Flaim SF (1982) Alterations in vasomotor tone in congestive heart failure. Progr Cardiovas Dis 24:437\u2013459","journal-title":"Progr Cardiovas Dis"},{"key":"BF00810519_CR53","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/j.1365-2362.1990.tb01796.x","volume":"20","author":"L Edvinsson","year":"1990","unstructured":"Edvinsson L, Ekman R, Hedner P, Valdemarsson S (1990) Congestive heart failure: involvement of perivascular peptides reflecting activity in sympathetic, parasympathetic and afferent fibres. Eur J Clin Invest 20:85\u201389","journal-title":"Eur J Clin Invest"},{"key":"BF00810519_CR54","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1748-1716.1980.tb06638.x","volume":"110","author":"JM Lundberg","year":"1980","unstructured":"Lundberg JM, H\u00f6kfelt T, Angg\u00e5rd A, Kimmil J, Goldstein M, Markey M (1980) Coexistence of an avian pancreatic polypeptide (APP) immunoreactive substance and catecholamines in some peripheral and central neurons. Acta Physiol Scand 110:107\u2013109","journal-title":"Acta Physiol Scand"},{"key":"BF00810519_CR55","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/0167-0115(84)90064-8","volume":"8","author":"E Ekblad","year":"1984","unstructured":"Ekblad E, Edvinsson L, Wahlestedt C, Uddman R, Hakanson R, Sundler F (1984) Neuropeptide Y co-exists and co-operates with noradrenaline in perivascular nerve fibres. Regul Peptides 8:225\u2013235","journal-title":"Regul Peptides"},{"key":"BF00810519_CR56","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1161\/01.RES.65.6.1536","volume":"65","author":"MR Warner","year":"1989","unstructured":"Warner MR, Levy MN (1989) Inhibition of cardiac vagal effects by neurally released and exogenous neuropeptide Y. Circ Res 65:1536\u20131546","journal-title":"Circ Res"},{"key":"BF00810519_CR57","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1161\/01.CIR.83.3.774","volume":"83","author":"J Clarke","year":"1991","unstructured":"Clarke J, Benjamin N, Larkin S, Webb D, Maseri A, Davies G (1991) Interaction of neuropeptide Y and the sympathetic nervous system in vascular control in man. Circulation 83:774\u2013777","journal-title":"Circulation"},{"key":"BF00810519_CR58","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/0002-9343(89)90228-3","volume":"86","author":"AS Maisel","year":"1989","unstructured":"Maisel AS, Scott NA, Motulsky HJ et al. (1989) Elevation of plasma neuropeptide Y levels in congestive heart failure. Am J Med 86:43\u201348","journal-title":"Am J Med"},{"key":"BF00810519_CR59","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1093\/cvr\/24.2.102","volume":"24","author":"J Hulting","year":"1990","unstructured":"Hulting J, Sollevi A, Ullman B, Frano-Cereceda A, Lundberg JM (1990) Plasma neuropeptide Y on admission to a coronary care unit: raised levels in patients with left heart failure. Cardiovasc Res 24:102\u2013108","journal-title":"Cardiovasc Res"},{"key":"BF00810519_CR60","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1111\/j.1475-097X.1986.tb00789.x","volume":"6","author":"J Pernow","year":"1986","unstructured":"Pernow J, Lundberg JM, Kaijser L et al. (1986) Plasma neuropeptide Y-like immunoreactivity and catecholamines during various degrees of sympathetic activation in man. Clin Physiol 6:561\u2013578","journal-title":"Clin Physiol"},{"key":"BF00810519_CR61","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1073\/pnas.77.3.1651","volume":"77","author":"JM Lundberg","year":"1980","unstructured":"Lundberg JM, Angg\u00e5rd A, Fahrenkrug J, H\u00f6kfelt T, Mutt V (1980) Vasoactive intestinal polypeptide in cholinergic neurons of exocrine glands. Functional significance of coexisting transmitters for vasodilation and secretion. Proc Natl Acad Sci USA 77:1651\u20131655","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF00810519_CR62","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/j.1748-1716.1986.tb07834.x","volume":"126","author":"JM Allen","year":"1986","unstructured":"Allen JM, Gj\u00f6rstrup P, Bj\u00f6rkman JA, Ek L, Abrahamsson T, Bloom SR (1986) Studies on cardiac distribution and function of neuropeptide Y. Acta Physiol Scand 126:405\u2013411","journal-title":"Acta Physiol Scand"},{"key":"BF00810519_CR63","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0014-2999(90)90335-4","volume":"187","author":"Y Karasawa","year":"1990","unstructured":"Karasawa Y, Furukawa Y, Ren L-M et al. (1990) Cardiac responses to VIP and VIP-ergic-cholinergic interaction in isolated dog heart preparations. Eur J Pharmacol 187:9\u201317","journal-title":"Eur J Pharmacol"},{"key":"BF00810519_CR64","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1016\/0002-9149(87)90619-9","volume":"60","author":"LL Frase","year":"1987","unstructured":"Frase LL, Gaffney A, Lane LD et al. (1987) Cardiovascular effects of vasoactive intestinal peptide in healthy subjects. Am J Cardiol 60:1356\u20131361","journal-title":"Am J Cardiol"},{"key":"BF00810519_CR65","first-page":"H1254","volume":"257","author":"TC Smitherman","year":"1989","unstructured":"Smitherman TC, Popma JJ, Said SI, Krejs GJ, Dehmer GJ (1989) Coronary hemodynamic effects of intravenous vasoactive intestinal peptide in humans. Am J Physiol 257:H1254\u20131262","journal-title":"Am J Physiol"},{"key":"BF00810519_CR66","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/S0140-6736(83)92232-8","volume":"i","author":"AJL Clark","year":"1983","unstructured":"Clark AJL, Adrian TE, McMichael HB, Bloom SR (1983) Vasoactive intestinal peptide in shock and heart failure (letter). Lancet i:539","journal-title":"Lancet"},{"key":"BF00810519_CR67","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/0306-3623(87)90027-9","volume":"18","author":"L Woie","year":"1987","unstructured":"Woie L, Dickstein K, Kaada B (1987) Increase in vasoactive intestinal polypeptides (VIP) by the angiotensin converting enzyme (ACE) inhibitor lisinopril in congestive heart failure. Relation to haemodynamic and hormonal changes. Gen Pharmacol 18:577\u2013587","journal-title":"Gen Pharmacol"},{"issue":"Suppl","key":"BF00810519_CR68","first-page":"149","volume":"13","author":"JM Polak","year":"1978","unstructured":"Polak JM, Ghatei MA, Wharton J, Bishop AE, Bloom SR (1978) Bombesin-like immunoreactivity in the gastrointestinal tract, lung and central nervous system. Scand J Gastroenterol 13 (Suppl):149","journal-title":"Scand J Gastroenterol"},{"key":"BF00810519_CR69","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1093\/cvr\/23.8.674","volume":"23","author":"C Ceconi","year":"1989","unstructured":"Ceconi C, Condorelli E, Quinzanini M, Rodella A, Ferrari R, Harris P (1989) Noradrenaline, atrial natriuretic peptide, bombesin and neurotensin in myocardium and blood of rats in congestive cardiac failure. Cardiovasc Res 23:674\u2013682","journal-title":"Cardiovasc Res"},{"key":"BF00810519_CR70","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/0006-8993(84)91066-7","volume":"308","author":"M Goedert","year":"1984","unstructured":"Goedert M, Sturmey N, Williams BJ, Emson PC (1984) The comparative distribution of xenopsin- and neurotensin-like immunoreactivity in Xenopus laevis and rat tissues. Brain Res 308:273\u2013280","journal-title":"Brain Res"},{"key":"BF00810519_CR71","first-page":"R726","volume":"257","author":"BC Wang","year":"1989","unstructured":"Wang BC, Bie P, Leadley RJ, Goetz KL (1989) Cardiovascular effects of calcitonin gene-related peptide in conscious dogs. Am J Physiol 257:R726\u2013731","journal-title":"Am J Physiol"},{"key":"BF00810519_CR72","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1038\/344770a0","volume":"344","author":"MT Nelson","year":"1990","unstructured":"Nelson MT, Huang Y, Brayden JE, Hescheler J, Standen NB (1990) Arterial dilations in response to calcitonin gene-related peptide involves activation of K+ channels. Nature 344:770\u2013773","journal-title":"Nature"},{"key":"BF00810519_CR73","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1136\/bmj.302.6779.739","volume":"302","author":"DJ O'Halloran","year":"1991","unstructured":"O'Halloran DJ, Bloom SR (1991) Calcitonin gene-related peptide. A major neuropeptide and the most powerful vasodilator known. Br Med J 302:739\u2013740","journal-title":"Br Med J"},{"key":"BF00810519_CR74","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/0140-6736(91)91035-S","volume":"338","author":"I Odar-Cederlof","year":"1991","unstructured":"Odar-Cederlof I, Theodorsson E, Ericsson F, Kjellstrand CM (1991) Plasma concentrations of calcitonin gene-related peptide in fluid overload. Lancet 338:411\u2013412","journal-title":"Lancet"},{"key":"BF00810519_CR75","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1093\/cvr\/24.3.239","volume":"24","author":"C Gennari","year":"1990","unstructured":"Gennari C, Nami R, Agnusdei D, Fischer JA (1990) Improved cardiac performance with human calcitonin generelated peptide in patients with congestive heart failure. Cardiovasc Res 24:239\u2013241","journal-title":"Cardiovasc Res"},{"key":"BF00810519_CR76","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1093\/oxfordjournals.eurheartj.a060103","volume":"13","author":"RJ Cody","year":"1992","unstructured":"Cody RJ (1992) The potential role of endothelin as a vasoconstrictor substance in congestive heart failure \u2014 role of ET1 in vasoconstriction. Eur Heart J 13:1573\u20131578","journal-title":"Eur Heart J"},{"key":"BF00810519_CR77","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1161\/01.CIR.89.4.1580","volume":"89","author":"C-M Wei","year":"1994","unstructured":"Wei C-M, Lerman A, Rodeheffer RJ et al. (1994) Endothelin in human congestive heart failure. Circulation 89:1580\u20131586","journal-title":"Circulation"},{"key":"BF00810519_CR78","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1161\/01.RES.4.1.85","volume":"5","author":"JP Henry","year":"1956","unstructured":"Henry JP, Gauer ON, Reeves JL (1956) Evidence on the atrial location of receptors influencing urine flow. Circ Res 5:85\u201390","journal-title":"Circ Res"},{"key":"BF00810519_CR79","first-page":"1","volume":"53","author":"HE De Wardener","year":"1977","unstructured":"De Wardener HE (1977) Natriuretic hormone. Clin Sci Mol Med 53:1\u20138","journal-title":"Clin Sci Mol Med"},{"key":"BF00810519_CR80","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/0024-3205(81)90370-2","volume":"28","author":"AJ De Bold","year":"1981","unstructured":"De Bold AJ, Borenstein HB, Veress AT, Sonnenberg H (1981) A rapid and potent natriuretic response to intravenous injection of atrial myocardial extracts in rats. Life Sci 28:89\u201394","journal-title":"Life Sci"},{"key":"BF00810519_CR81","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1038\/314264a0","volume":"314","author":"RE Lang","year":"1985","unstructured":"Lang RE, Th\u00f6lken H, Ganten D, Luft FC, Ruskoaho H, Unger T (1985) Atrial natriuretic factor \u2014 a circulating hormone stimulated by volume loading. Nature 314:264\u2013266","journal-title":"Nature"},{"key":"BF00810519_CR82","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/S0006-291X(88)80555-2","volume":"155","author":"T Sudoh","year":"1988","unstructured":"Sudoh T, Minamino N, Kangawa K, Matsuo H (1988) BNP-32, N-terminally six amino acid extended form of BNP identified in porcine brain. Biochem Biophys Res Comm 155:726\u2013732","journal-title":"Biochem Biophys Res Comm"},{"key":"BF00810519_CR83","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/0006-291X(90)92401-K","volume":"168","author":"T Sudoh","year":"1990","unstructured":"Sudoh T, Minamino N, Kangawa K, Matsuo H (1990) CNP: a new member of the natriuretic peptide family identified in porcine brain. Biochem Biophys Res Comm 168:863\u2013870","journal-title":"Biophys Res Comm"},{"key":"BF00810519_CR84","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1152\/physrev.1990.70.3.665","volume":"20","author":"BM Brenner","year":"1990","unstructured":"Brenner BM, Ballerman BJ, Gunning ME et al. (1990) Diverse biological actions of ANP. Physiol Rev 20:665\u2013699","journal-title":"Physiol Rev"},{"key":"BF00810519_CR85","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1172\/JCI113141","volume":"80","author":"T Fujita","year":"1987","unstructured":"Fujita T, Ito Y, Noda H et al. (1987) Vasodilatory actions of alpha-human atrial natriuretic peptide and high Ca2+ effects in normal man. J Clin Invest 80:832\u2013840","journal-title":"J Clin Invest"},{"key":"BF00810519_CR86","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/0002-8703(92)90754-J","volume":"123","author":"K Ando","year":"1992","unstructured":"Ando K, Ito Y, Ogata E, Fujita T (1992) Vasodilating actions of calcitonin gene-related peptide in normal man: comparison with atrial natriuretic peptide. Am Heart J 123:111\u2013116","journal-title":"Am Heart J"},{"key":"BF00810519_CR87","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1161\/01.RES.62.2.191","volume":"62","author":"BS Edwards","year":"1988","unstructured":"Edwards BS, Zimmerman RS, Schwab TR, heublein DM, Burnett JC (1988) Atrial stretch, not pressure, is the principal determinant controlling the release of atrial natriuretic factor. Circ Res 62:191\u2013195","journal-title":"Circ Res"},{"key":"BF00810519_CR88","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1093\/oxfordjournals.eurheartj.a059712","volume":"11","author":"ACM Ong","year":"1990","unstructured":"Ong ACM, Handler CE, Slater JDH (1990) ANP response to atrial stretch and not to atrial pressure: observation during pericardiocentesis in a young woman. Eur Heart J 11:368\u2013371","journal-title":"Eur Heart J"},{"key":"BF00810519_CR89","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1042\/cs0790377","volume":"79","author":"J Au","year":"1990","unstructured":"Au J, Brown JE, Lee MR, Boon NA (1990) Effect of cardiac tamponade on atrial natriuretic peptide concentrations: influence of stretch and pressure. Clin Sci 79:377\u2013380","journal-title":"Clin Sci"},{"key":"BF00810519_CR90","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1093\/cvr\/22.4.231","volume":"22","author":"MR Wilkins","year":"1988","unstructured":"Wilkins MR, Gammage MD, Lewis HM, Tan LB, Weissberg PL (1988) Effect of lower body positive pressure on blood pressure, plasma atrial natriuretic factor concentration, and sodium and water excretion in healthy volunteers and cardiac transplant recipients. Cardiovasc Res 22:231\u2013235","journal-title":"Cardiovasc Res"},{"key":"BF00810519_CR91","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1042\/cs0760423","volume":"76","author":"JV Anderson","year":"1989","unstructured":"Anderson JV, Maxwell DL, Payne NN, Slater JDH, Bloom SR (1989) Atrial natriuretic peptide: physiological release associated with natriuresis during negative pressure breathing in man. Clin Sci 76:423\u2013429","journal-title":"Clin Sci"},{"key":"BF00810519_CR92","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1042\/cs0800475","volume":"80","author":"LC Warner","year":"1991","unstructured":"Warner LC, Morali GA, Miller JA, Logan AG, Skorecki KL, Blendis LM (1991) Aldosterone, atrial natriuretic factor and sodium intake as determinants of the natriuretic responses to head-out water immersion in healthy subjects. Clin Sci 80:475\u2013480","journal-title":"Clin Sci"},{"key":"BF00810519_CR93","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1056\/NEJM198510033131416","volume":"313","author":"H Nakaoka","year":"1985","unstructured":"Nakaoka H, Imataka K, Amano M, Fujii J, Ishibashi M, Yamaji T (1985) Plasma levels of atrial natriuretic factor in patients with congestive heart failure. N Engl J Med 313:892\u2013893","journal-title":"N Engl J Med"},{"key":"BF00810519_CR94","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1172\/JCI112154","volume":"76","author":"Y Shenker","year":"1985","unstructured":"Shenker Y, Sider RS, Ostafin EA, Grekin RJ (1985) Plasma immunoreactive atrial natriuretic factor in healthy subjects and in patients with edema. J Clin Invest 76:1684\u20131687","journal-title":"J Clin Invest"},{"key":"BF00810519_CR95","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/S0140-6736(85)90178-3","volume":"ii","author":"I Tikkanen","year":"1985","unstructured":"Tikkanen I, Fyhrquist F, Mets\u00e4rinne K, Leidenius R (1985) Plasma atrial natriuretic peptide in cardiac disease and during infusion in healthy volunteers. Lancet ii:66\u201369","journal-title":"Lancet"},{"key":"BF00810519_CR96","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1136\/bmj.293.6544.409","volume":"293","author":"AM Richards","year":"1986","unstructured":"Richards AM, Cleland JGF, Tonolo G et al. (1986) Plasma \u03b1-natriuretic peptide in cardiac impairment. Br Med J 293:409\u2013412","journal-title":"Br Med J"},{"key":"BF00810519_CR97","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1126\/science.2935937","volume":"231","author":"JC Burnett","year":"1986","unstructured":"Burnett JC, Kao PC, Hu DC et al. (1986) Atrial natriuretic peptide elevation in congestive heart failure in the human. Science 231:1145\u20131147","journal-title":"Science"},{"key":"BF00810519_CR98","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1056\/NEJM198608283150901","volume":"315","author":"AEG Raine","year":"1986","unstructured":"Raine AEG, Erne P, B\u00fcrgisser E et al. (1986) Atrial natriuretic peptide and atrial pressure in patients with congestive heart failure. N Engl J Med 315:533\u2013537","journal-title":"N Engl J Med"},{"key":"BF00810519_CR99","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1093\/oxfordjournals.eurheartj.a062124","volume":"7","author":"A Pettersson","year":"1986","unstructured":"Pettersson A, Hedner J, Hedner T, Held P, Swedberg K, Towle AC (1986) Increased plasma levels of atrial natriuretic peptide in patients with congestive heart failure. Eur Heart J 7:693\u2013696","journal-title":"Eur Heart J"},{"key":"BF00810519_CR100","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1093\/oxfordjournals.eurheartj.a059898","volume":"12","author":"JE Donckier","year":"1991","unstructured":"Donckier JE, De Coster PM, Vanoverschelde J-L et al. (1991) Atrial natriuretic factor, cardiac volumes and filling pressures during exercise in congestive heart failure. Eur Heart J 12:322\u2013327","journal-title":"Eur Heart J"},{"key":"BF00810519_CR101","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1530\/acta.0.1180168","volume":"118","author":"N Keller","year":"1988","unstructured":"Keller N, Larsen J, Sykulski R, Storm T, Thamsborg G (1988) Atrial natriuretic factor during exercise in patients with congestive heart failure. Acta Endocrinol 118:168\u2013172","journal-title":"Acta Endocrinol"},{"key":"BF00810519_CR102","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1126\/science.6538050","volume":"223","author":"JE Chimoskey","year":"1984","unstructured":"Chimoskey JE, Spielman WS, Brandt MA, Heidemann SR (1984) Cardiac cotria of BIO 14.6 hamsters are deficient in natriuretic factor. Science 223:820\u2013822","journal-title":"Science"},{"key":"BF00810519_CR103","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1042\/bj2410265","volume":"241","author":"G Thibauld","year":"1987","unstructured":"Thibauld G, Garcia R, Gutkowska J et al. (1987) The propeptide Asn 1-Tyr 126 is the storage form of rat atrial natriuretic factor. Biochem J 241:265\u2013272","journal-title":"Biochem J"},{"key":"BF00810519_CR104","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1042\/bj2320313","volume":"232","author":"TG Flynn","year":"1985","unstructured":"Flynn TG, Davies PL (1985) The biochemistry and molecular biology of ANF. Biochem J 232:313\u2013321","journal-title":"Biochem J"},{"key":"BF00810519_CR105","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1016\/0024-3205(86)90137-2","volume":"38","author":"TG Yandle","year":"1986","unstructured":"Yandle TG, Richards AM, Nicholls MG, Cuneo R, Espiner EA, Livesey JH (1986) Metabolic clearance rate and plasma half-life of alpha-human atrial natriuretic peptide in man. Life Sci 38:1827\u20131833","journal-title":"Life Sci"},{"key":"BF00810519_CR106","first-page":"455","volume":"45","author":"MB Anand-Srivastava","year":"1993","unstructured":"Anand-Srivastava MB, Trachte GJ (1993) Atrial natriuretic factor receptors and signal transduction mechanisms. Pharmacol Rev 45:455\u2013497","journal-title":"Pharmacol Rev"},{"key":"BF00810519_CR107","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1161\/01.CIR.87.1.70","volume":"87","author":"T Tsutamoto","year":"1993","unstructured":"Tsutamoto T, Kanamori T, Morigami N, Sugimoto Y, Yamaoka O, Kinoshita M (1993) Possibility of down-regulation of atrial natriuretic peptide receptor coupled to guanylate cyclase in peripheral vascular beds of patients with chronic severe heart failure. Circulation 87:70\u201375","journal-title":"Circulation"},{"key":"BF00810519_CR108","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1161\/01.CIR.88.3.1016","volume":"88","author":"C-M Wei","year":"1993","unstructured":"Wei C-M, Kao PC, Lin J-T, Heublein DM, Schaff HV, Burnett JC (1993) Circulating \u03b2-atrial natriuretic factor in congestive heart failure in humans. Circulation 88:1016\u20131020","journal-title":"Circulation"},{"key":"BF00810519_CR109","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.1365-2362.1994.tb01084.x","volume":"24","author":"A-M Nugent","year":"1994","unstructured":"Nugent A-M, Onuoha GN, McEneaney DJ et al. (1994) Variable patterns of atrial natriuretic peptide secretion in man. Eur J Clin Invest 24:267\u2013274","journal-title":"Eur J Clin Invest"},{"key":"BF00810519_CR110","doi-asserted-by":"crossref","first-page":"764","DOI":"10.2337\/diab.36.6.764","volume":"36","author":"DS Weigle","year":"1987","unstructured":"Weigle DS (1987) Pulsatile secretion of fuel-regulatory hormones. Diabetes 36:764\u2013775","journal-title":"Diabetes"},{"issue":"Suppl 1","key":"BF00810519_CR111","first-page":"A6","volume":"23","author":"GN Onuoha","year":"1993","unstructured":"Onuoha GN, Nugent A-M, Steele IC et al. (1993) Pattern of neuropeptide secretion in ischaemic heart disease. Eur J Clin Invest 23 (Suppl 1):A6","journal-title":"Eur J Clin Invest"},{"key":"BF00810519_CR112","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/0735-1097(91)90601-5","volume":"18","author":"H Hayakawa","year":"1991","unstructured":"Hayakawa H (1991) Disturbed secretion of atrial natriuretic peptide in patients with persistent atrial standstill: endocrinologic silence. J Am Coll Cardiol 18:459\u2013463","journal-title":"J Am Coll Cardiol"},{"key":"BF00810519_CR113","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/0014-5793(90)80043-I","volume":"259","author":"Y Kambayashi","year":"1990","unstructured":"Kambayashi Y, Nakao K, Mukoyama M et al. (1990) Isolation and sequence determination of human brain natriuretic peptide in human atrium. FEBS Lett 259:341\u2013345","journal-title":"FEBS Lett"},{"key":"BF00810519_CR114","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1042\/cs0830519","volume":"83","author":"CC Lang","year":"1992","unstructured":"Lang CC, Choy A-MJ, Struthers AD (1992) Atrial and brain natriuretic peptide: a dual natriuretic peptide system, potentially involved in circulatory homeostasis. Clin Sci 83:519\u2013527","journal-title":"Clin Sci"},{"key":"BF00810519_CR115","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1172\/JCI115146","volume":"87","author":"M Mukoyama","year":"1991","unstructured":"Mukoyama M, Nakao K, Hosoda K et al. (1991) Brain natriuretic peptide as a novel cardiac hormone in humans. Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide. J Clin Invest 87:1402\u20131412","journal-title":"J Clin Invest"},{"key":"BF00810519_CR116","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1042\/cs0860723","volume":"86","author":"BMY Cheung","year":"1994","unstructured":"Cheung BMY, Dickerson JEC, Ashby MJ, Brown MJ, Brown J (1994) Effects of physiological increments in human \u03b1-atrial natriuretic peptide and human brain natriuretic peptide in normal male subjects. Clin Sci 86:723\u2013730","journal-title":"Clin Sci"},{"key":"BF00810519_CR117","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1042\/cs0820619","volume":"82","author":"CC Lang","year":"1992","unstructured":"Lang CC, Motwani JG, Coutie WJR, Struthers AD (1992) Clearance of brain natriuretic peptide in patients with chronic heart failure: indirect evidence for a neutral endopeptidase mechanism but against an atrial natriuretic peptide clearance receptor mechanism. Clin Sci 82:619\u2013623","journal-title":"Clin Sci"},{"key":"BF00810519_CR118","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1056\/NEJM199009133231114","volume":"323","author":"M Mukoyama","year":"1990","unstructured":"Mukoyama M, Nakao K, Saito Y et al. (1990) Increased human brain natriuretic peptide in congestive heart failure. N Engl J Med 323:757\u2013758","journal-title":"N Engl J Med"},{"key":"BF00810519_CR119","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/S0140-6736(94)92690-5","volume":"343","author":"M Davis","year":"1994","unstructured":"Davis M, Espiner E, Richards G et al. (1994) Plasma brain natriuretic peptide in assessment of acute dyspnoea. Lancet 343:440\u2013444","journal-title":"Lancet"},{"key":"BF00810519_CR120","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1136\/hrt.70.5.397","volume":"70","author":"AD Struthers","year":"1993","unstructured":"Struthers AD (1993) Plasma concentration of brain natriuretic peptide: will this new test reduce the need for cardiac investigations? Br Heart J 70:397\u2013398","journal-title":"Br Heart J"},{"key":"BF00810519_CR121","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1136\/hrt.72.1.16","volume":"72","author":"A-MJ Choy","year":"1994","unstructured":"Choy A-MJ, Darbar D, Lang CC et al. (1994) Detection of left ventricular dysfunction after acute myocardial infarction: comparison of clinical, echocardiographic, and neurohormonal methods. Br Heart J 72:16\u201322","journal-title":"Br Heart J"},{"key":"BF00810519_CR122","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/0140-6736(93)93126-L","volume":"341","author":"JG Motwani","year":"1993","unstructured":"Motwani JG, McAlpine H, Kennedy N, Struthers AD (1993) Plasma brain natriuretic peptide as an indicator for angiotensin-converting-enzyme inhibition after myocardial infarction. Lancet 341:1109\u20131113","journal-title":"Lancet"},{"key":"BF00810519_CR123","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.1001\/jama.1992.03480190067033","volume":"267","author":"KM Davis","year":"1992","unstructured":"Davis KM, Fish LC, Elahi D, Clark BA, Minaker KL (1992) Atrial natriuretic peptide levels in the prediction of congestive heart failure risk in frail elderly. J Am Med Assoc 267:2625\u20132629","journal-title":"J Am Med Assoc"},{"issue":"Abstr Suppl","key":"BF00810519_CR124","first-page":"552","volume":"15","author":"GN Onuoha","year":"1994","unstructured":"Onuoha GN, Shaw C, Nugent A-M et al. (1994) Brain and atrial natriuretic peptides during exercise. Eur Heart J 15 (Abstr Suppl): 552","journal-title":"Eur Heart J"},{"issue":"Suppl","key":"BF00810519_CR125","first-page":"215A","volume":"23","author":"A Matsumoto","year":"1994","unstructured":"Matsumoto A, Hirata Y, Monomura S et al. (1994) Effect of exercise on plasma level of brain natriuretic peptide in congestive heart failure with and without left ventricular dysfunction. J Am Coll Cardiol 23 (Suppl):215A","journal-title":"J Am Coll Cardiol"},{"key":"BF00810519_CR126","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/0006-291X(91)91614-I","volume":"175","author":"Y Tawaragi","year":"1991","unstructured":"Tawaragi Y, Fuchimura K, Tanaka S, Minamino N, Kangawa K, Matsuo H (1991) Gene and precursor structure of human C-type natriuretic peptide. Biochem Biophys Res Commun 175:645\u2013651","journal-title":"Biochem Biophys Res Commun"},{"key":"BF00810519_CR127","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1210\/endo-129-2-1104","volume":"129","author":"Y Komatsu","year":"1991","unstructured":"Komatsu Y, Nakao K, Suga S et al. (1991) C-type natriuretic peptide (CNP) in rats and humans. Endocrinology 129:1104\u20131106","journal-title":"Endocrinology"},{"key":"BF00810519_CR128","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/0006-8993(93)91649-D","volume":"612","author":"T Kaneko","year":"1993","unstructured":"Kaneko T, Shirakami G, Nakao K et al. (1993) C-type natriuretic peptide (CNP) is the major natriuretic peptide in human cerebro-spinal fluid. Brain Res 612:104\u2013109","journal-title":"Brain Res"},{"key":"BF00810519_CR129","first-page":"R290","volume":"264","author":"AL Clavell","year":"1993","unstructured":"Clavell AL, Stingo AJ, Wei C-M, Heublein DM, Burnett JC (1993) C-type natriuretic peptide: a selective cardiovascular profile. Am J Physiol 264:R290\u2013295","journal-title":"Am J Physiol"},{"key":"BF00810519_CR130","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/0006-291X(92)90530-X","volume":"183","author":"P Vigne","year":"1992","unstructured":"Vigne P, Frelin C (1992) C-type natriuretic peptide is a potent activator of guanylate cyclase in endothelial cells from brain microvessels. Biochem Biophys Res Commun 183:640\u2013644","journal-title":"Biochem Biophys Res Commun"},{"key":"BF00810519_CR131","doi-asserted-by":"crossref","first-page":"H71","DOI":"10.1152\/ajpcell.1993.264.1.C71","volume":"264","author":"C-M Wei","year":"1993","unstructured":"Wei C-M, Aarhus LL, Miller VM, Burnett JC (1993) Action of C-type natriuretic peptide in isolated canine arteries and veins. Am J Physiol 264:H71\u201373","journal-title":"Am J Physiol"},{"key":"BF00810519_CR132","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1161\/01.CIR.88.3.1004","volume":"88","author":"C-M Wei","year":"1993","unstructured":"Wei C-M, Heublein DM, Perrella MA et al. (1993) Natriuretic peptide system in human heart failure. Circulation 88:1004\u20131009","journal-title":"Circulation"},{"issue":"Suppl","key":"BF00810519_CR133","first-page":"73","volume":"71","author":"CS Barr","year":"1994","unstructured":"Barr CS, Cargill RJ, Coutie WJ, Struthers AD, Lipworth BJ (1994) Circulating levels of C-type natriuretic peptide in patients with left ventricular dysfunction and hypoxaemic pulmonary heart disease. Br Heart J 71 (Suppl):P73","journal-title":"Br Heart J"},{"key":"BF00810519_CR134","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1136\/bmj.308.6944.1615","volume":"308","author":"AD Struthers","year":"1994","unstructured":"Struthers AD (1994) Ten years of natriuretic peptide research: a new dawn for their diagnostic and therapeutic use? Br Med J 308:1615\u20131619","journal-title":"Br Med J"},{"key":"BF00810519_CR135","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1161\/01.CIR.84.4.1581","volume":"84","author":"M Yoshimura","year":"1991","unstructured":"Yoshimura M, Yasue H, Morita E et al. (1991) Haemodynamic, renal, and hormonal responses to BNP in patients with congestive heart failure. Circulation 84:1581\u20131588","journal-title":"Circulation"},{"key":"BF00810519_CR136","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/S0140-6736(89)90714-9","volume":"ii","author":"DB Northridge","year":"1989","unstructured":"Northridge DB, Jardine AG, Alabaster CT et al. (1989) Effects of UK 69578: a novel atriopeptidase inhibitor. Lancet ii:591\u2013593","journal-title":"Lancet"},{"key":"BF00810519_CR137","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1172\/JCI116800","volume":"92","author":"C-M Wei","year":"1993","unstructured":"Wei C-M, Kim CH, Miller VM, Burnett JC (1993) Vasonatrin peptide: a unique synthetic natriuretic and vasorelaxing peptide. J Clin Invest 92:2048\u20132052","journal-title":"J Clin Invest"},{"key":"BF00810519_CR138","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1172\/JCI116744","volume":"92","author":"DG Gardner","year":"1993","unstructured":"Gardner DG (1993) Designer natriuretic peptides. J Clin Invest 92:1606\u20131607","journal-title":"J Clin Invest"},{"issue":"Suppl A","key":"BF00810519_CR139","doi-asserted-by":"crossref","first-page":"93A","DOI":"10.1016\/0735-1097(93)90469-H","volume":"22","author":"JR Wilson","year":"1993","unstructured":"Wilson JR, Mancini DM (1993) Factors contributing to the exercise limitation of heart failure. J Am Coll Cardiol 22 (Suppl A):93A-98A","journal-title":"J Am Coll Cardiol"},{"key":"BF00810519_CR140","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1136\/hrt.58.3.190","volume":"58","author":"P Harris","year":"1987","unstructured":"Harris P (1987) Congestive cardiac failure: central role of the arterial blood pressure. Br Heart J 58:190\u2013203","journal-title":"Br Heart J"}],"container-title":["Basic Research in Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00810519.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/BF00810519\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00810519.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,15]],"date-time":"2022-02-15T19:34:24Z","timestamp":1644953664000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/BF00810519"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1996,1]]},"references-count":140,"journal-issue":{"issue":"S1","published-print":{"date-parts":[[1996,1]]}},"alternative-id":["BF00810519"],"URL":"https:\/\/doi.org\/10.1007\/bf00810519","relation":{},"ISSN":["0300-8428","1435-1803"],"issn-type":[{"value":"0300-8428","type":"print"},{"value":"1435-1803","type":"electronic"}],"subject":[],"published":{"date-parts":[[1996,1]]}}}